17342-08-4 Usage
Description
L-Pyroglutaminol, also known as (S)-Pyroglutaminol, is a compound that is valuable in the field of organic synthesis. It is characterized by its white to light yellow crystalline appearance and possesses unique chemical properties that make it a versatile component in various chemical reactions and processes.
Uses
Used in Organic Synthesis:
L-Pyroglutaminol is used as a key compound in organic synthesis for its ability to participate in a wide range of chemical reactions. Its unique chemical properties allow it to be a versatile building block in the creation of more complex molecules and structures.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, L-Pyroglutaminol is used as an intermediate in the synthesis of various drugs and medications. Its role in creating complex molecular structures makes it an essential component in the development of new and innovative pharmaceutical products.
Used in Chemical Research:
L-Pyroglutaminol is also utilized in chemical research as a tool to study and understand the behavior of different chemical reactions. Its unique properties and reactivity make it an ideal candidate for exploring new reaction pathways and mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 17342-08-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,3,4 and 2 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17342-08:
(7*1)+(6*7)+(5*3)+(4*4)+(3*2)+(2*0)+(1*8)=94
94 % 10 = 4
So 17342-08-4 is a valid CAS Registry Number.
17342-08-4Relevant articles and documents
INHIBITORS OF APOL1 AND METHODS OF USING SAME
-
, (2020/07/14)
The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).
Biphenyl compound as well as preparation method and medical application thereof
-
Paragraph 1517-1523, (2020/11/22)
The invention discloses a biphenyl compound as well as a preparation method and medical application thereof, the structure of the biphenyl compound is shown as a formula (I) or a formula (II), and thebiphenyl compound or pharmaceutically acceptable salt, tautomer, meso-isomer, raceme, stereoisomer, metabolite, metabolite precursor, prodrug or solvate thereof is a PD-L1 inhibitor. The compound hasa remarkable inhibiting effect on the interaction of PD-1 and PD-L1 protein, so that the compound can be applied to the preparation of PD-L1 inhibitors and immunomodulator drugs for preventing or treating tumors, autoimmune diseases, organ transplant rejection, infectious diseases and inflammatory diseases.
5-HT7 Receptor Antagonists with an Unprecedented Selectivity Profile
Ates, Ali,Burssens, Pierre,Lorthioir, Olivier,Lo Brutto, Patrick,Dehon, Gwenael,Keyaerts, Jean,Coloretti, Francis,Lallemand, Bénédicte,Verbois, Valérie,Gillard, Michel,Vermeiren, Céline
, p. 795 - 802 (2018/04/02)
-